Neurontin Class Action To Include Generics Buyers
By Brendan Pierson · March 24, 2008, 12:00 AM EDT
A Philadelphia judge has ruled that Pfizer Inc. can be held liable for off-label marketing of generic versions of its blockbuster epilepsy drug Neurontin, allowing a class action including people who...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login